Smoothened Variants Explain the Majority of Drug Resistance in Basal Cell Carcinoma
2015 · Cancer Cell · 415 citations
https://doi.org/10.1016/j.ccell.2015.02.002
M
Mina S. Ally
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
29
Papers
1.4K
Citations
20
h-index
22
i10-index
Mina S. Ally is an academic researcher from Stanford University. The author has contributed to research in topics: Hedgehog Signaling Pathway Studies & Cancer and Skin Lesions & Nonmelanoma Skin Cancer Studies. The author has an h-index of 20, co-authored 25 publications.
Papers by this author
worksAn investigator-initiated open-label clinical trial of vismodegib as a neoadjuvant to surgery for high-risk basal cell carcinoma
2014 · Journal of the American Academy of Dermatology · 141 citations
https://doi.org/10.1016/j.jaad.2014.05.020
Inhibition of the hedgehog pathway in patients with basal-cell nevus syndrome: final results from the multicentre, randomised, double-blind, placebo-controlled, phase 2 trial
2016 · The Lancet Oncology · 134 citations
https://doi.org/10.1016/s1470-2045(16)30566-6
Cutaneous Human Papillomavirus Infection and Basal Cell Carcinoma of the Skin
2013 · Journal of Investigative Dermatology · 22 citations
https://doi.org/10.1038/jid.2013.46
Supplementary Material for: Limited Role of Random Skin Biopsy in the Diagnosis of Intravascular Lymphoma in Adult Patients with Hemophagocytic Lymphohistiocytosis
2017 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.5161306
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat